Vistagen Therapeutics (VTGN) Leases (2019 - 2025)
Vistagen Therapeutics (VTGN) has disclosed Leases for 7 consecutive years, with $939000.0 as the latest value for Q4 2025.
- Quarterly Leases fell 35.73% to $939000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $939000.0 through Dec 2025, down 35.73% year-over-year, with the annual reading at $1.3 million for FY2025, 26.65% down from the prior year.
- Leases hit $939000.0 in Q4 2025 for Vistagen Therapeutics, down from $1.1 million in the prior quarter.
- In the past five years, Leases ranged from a high of $3.2 million in Q1 2021 to a low of $1600.0 in Q2 2021.
- Historically, Leases has averaged $1.9 million across 5 years, with a median of $2.0 million in 2023.
- Biggest five-year swings in Leases: crashed 99.95% in 2021 and later surged 160212.5% in 2022.
- Year by year, Leases stood at $2.8 million in 2021, then dropped by 14.24% to $2.4 million in 2022, then decreased by 18.21% to $1.9 million in 2023, then decreased by 24.44% to $1.5 million in 2024, then plummeted by 35.73% to $939000.0 in 2025.
- Business Quant data shows Leases for VTGN at $939000.0 in Q4 2025, $1.1 million in Q3 2025, and $1.2 million in Q2 2025.